文献速递认知障碍与痴呆

阿尔茨海默病tau病理的脑与认知韧性相关因素分析

Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
PubMed 文献 · JAMA Neurol · 2020-01-01

该横断面与纵向研究纳入260例淀粉样蛋白β阳性的轻度认知障碍或阿尔茨海默病痴呆患者,评估人口学、遗传和神经影像因素与tau PET负荷所致脑韧性和认知韧性的关联。结果显示女性及年轻患者脑韧性更高,教育程度高和全皮层厚度大与认知韧性更高相关,脑与认知韧性均低者认知下降最快。

要点

  • 女性及年轻AD患者对病理性tau的脑结构韧性相对保留。
  • 较高教育水平和全皮层厚度与更高的认知韧性相关。
  • 脑韧性与认知韧性均低的患者认知下降速度最快。

核心结论

  • 女性和年轻AD患者在暴露于新皮层病理性tau时脑结构相对保留。
  • 对病理性tau的韧性个体差异可能影响疾病进展,脑与认知韧性均低者认知下降最快。

研究设计与样本

  • 横断面与纵向研究,tau PET于2014年6月1日至2017年11月30日进行,全球认知随访平均2.0年(SD 1.8)。
  • 纳入韩国、瑞典和美国3个痴呆中心的260例淀粉样蛋白β阳性轻度认知障碍或AD痴呆患者。
  • 采用线性回归模型分别计算全皮层[18F]flortaucipir摄取与皮层厚度、MMSE的标准化残差作为脑韧性和认知韧性指标。

主要发现

  • 多变量模型中,女性(标准化β=-0.15,P=.02)和年轻患者(标准化β=-0.20,P=.006)脑韧性更高。
  • 较高教育水平(标准化β=0.23,P<.001)和全皮层厚度(标准化β=0.23,P<.001)与更高认知韧性相关。
  • 线性混合模型显示脑韧性×认知韧性×时间对MMSE的交互作用显著(β[SE]=-0.235[0.111],P=.03),脑与认知韧性均低者斜率最陡。

关键数值与推荐

  • 脑韧性定义为全皮层[18F]flortaucipir摄取与皮层厚度线性回归的标准化残差。
  • 认知韧性定义为全皮层[18F]flortaucipir摄取与MMSE线性回归的标准化残差。

临床怎么用

  • 临床评估AD患者时,可结合教育水平、皮层厚度及tau PET负荷综合判断认知韧性。
  • 对脑与认知韧性均低的患者,应更密切监测认知下降速度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Better understanding is needed of the degree to which individuals tolerate Alzheimer disease (AD)-like pathological tau with respect to brain structure (brain resilience) and cognition (cognitive resilience). OBJECTIVE: To examine the demographic (age, sex, and educational level), genetic (APOE-ε4 status), and neuroimaging (white matter hyperintensities and cortical thickness) factors associated with interindividual differences in brain and cognitive resilience to tau positron emission tomography (PET) load and to changes in global cognition over time. DESIGN, SETTING, AN PARTICIPANTS: In this cross-sectional, longitudinal study, tau PET was performed from June 1, 2014, to November 30, 2017, and global cognition monitored for a mean [SD] interval of 2.0 [1.8] years at 3 dementia centers in South Korea, Sweden, and the United States. The study included amyloid-β-positive participants with mild cognitive impairment or AD dementia. Data analysis was performed from October 26, 2018, to December 11, 2019. EXPOSURES: Standard dementia screening, cognitive testing, brain magnetic resonance imaging, amyloid-β PET and cerebrospinal fluid analysis, and flortaucipir (tau) labeled with fluor-18 (18F) PET. MAIN OUTCOMES AND MEASURES: Separate linear regression models were performed between whole cortex [18F]flortaucipir uptake and cortical thickness, and standardized residuals were used to obtain a measure of brain resilience. The same procedure was performed for whole cortex [18F]flortaucipir uptake vs Mini-Mental State Examination (MMSE) as a measure of cognitive resilience. Bivariate and multivariable linear regression models were conducted with age, sex, educational level, APOE-ε4 status, white matter hyperintensity volumes, and cortical thickness as independent variables and brain and cognitive resilience measures as dependent variables. Linear mixed models were performed to examine whether changes in MMSE scores over time differed as a function of a combined brain and cognitive resilience variable. RESULTS: A total of 260 participants (145 [55.8%] female; mean [SD] age, 69.2 [9.5] years; mean [SD] MMSE score, 21.9 [5.5]) were included in the study. In multivariable models, women (standardized β = -0.15, P = .02) and young patients (standardized β = -0.20, P = .006) had greater brain resilience to pathological tau. Higher educational level (standardized β = 0.23, P < .001) and global cortical thickness (standardized β = 0.23, P < .001) were associated with greater cognitive resilience to pathological tau. Linear mixed models indicated a significant interaction of brain resilience × cognitive resilience × time on MMSE (β [SE] = -0.235 [0.111], P = .03), with steepest slopes for individuals with both low brain and cognitive resilience. CONCLUSIONS AND RELEVANCE: Results of this study suggest that women and young patients with AD have relative preservation of brain structure when exposed to neocortical pathological tau. Interindividual differences in resilience to pathological tau may be important to disease progression because participants with both low brain and cognitive resilience had the most rapid cognitive decline over time.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Ossenkoppele R, Lyoo CH, Jester-Broms J, et al. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease. JAMA Neurol. 2020. PMID: 32091549. doi:10.1001/jamaneurol.2019.5154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。